alprostadil (Muse, Caverject, Edex, Prostin VR pediatric, Topiglan, Befar)
Jump to navigation
Jump to search
Introduction
Tradenames: Muse, Caverject, Edex, Prostin VR pediatric. Prostaglandin E1.
Indications
- impotence
- congenital heart defect
- temporary maintenance of patent ductus arteriosus in neonates with ductal-dependent congenital heart disease until surgery can be performed
- coarctation of the aorta[5]
- pulmonary hypertension
- peripheral vascular disease, peripheral arterial disease[4]
Contraindications
- intracavernous injection
Dosage
- impotence
- 1 intraurethral pellet (Muse)
- intracavernosal injection (Caverject, Edex)
- use lowest dose necessary to produce erection
- congenital heart disease
Muse: 125, 250, 500, 1000 ug.
Caverject: 6.15, 11.9, 23.3 ug
Edex: 5, 10, 20, 40 ug
Adverse effects
- common (> 10%)
- flushing
- fever
- penile pain
- apnea 2)less common (1-10%)
- bradycardia, hypotension, hypertension, tachycardia, cardiac arrest, edema, seizures, headache, dizziness, hypokalemia, diarrhea, prolonged erection, penile fibrosis, penile edema, disseminated intravascular coagulation, injection site hematoma or ecchymosis, back pain, upper respiratory tract infection, flu-like syndrome, sinusitis, nasal congestion, cough, sepsis, localized pain at sites other than the injection site
- uncommon (< 1%)
- cerebral bleeding, congestive heart failure, 2nd degree heart block, shock, supraventricular tachycardia, ventricular fibrillation, hyperemia, hyperirritability, hypothermia, jitteriness, lethargy, hypoglycemia, hyperkalemia, gastric regurgitation, anuria, balanitis, urethral bleeding, penile numbness, yeast infection, penile pruritus & erythema, abnormal ejaculation, anemia, bleeding, thrombocytopenia, hyperbilirubinemia, hyperextension of the neck, hematuria, bradypnea, wheezing, peritonitis
More general terms
Additional terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- ↑ 4.0 4.1 Department of Veterans Affairs, VA National Formulary
- ↑ 5.0 5.1 5.2 Deprecated Reference